Cite
Clinical outcomes with mepolizumab therapy in routine practice in the oxford cohort
MLA
Gittins, A., et al. Clinical Outcomes with Mepolizumab Therapy in Routine Practice in the Oxford Cohort. July 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1064..cd8e5a075942f4d2ee8ca1d9ebe3005e&authtype=sso&custid=ns315887.
APA
Gittins, A., Borg, C., Connolly, C., Hynes, G., Shrimanker, R., Thulborn, S., Gould, N., Cane, J., Pavord, I., & Hinks, T. (2019). Clinical outcomes with mepolizumab therapy in routine practice in the oxford cohort.
Chicago
Gittins, A, C Borg, C Connolly, G Hynes, R Shrimanker, S Thulborn, N Gould, J Cane, I Pavord, and T Hinks. 2019. “Clinical Outcomes with Mepolizumab Therapy in Routine Practice in the Oxford Cohort,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1064..cd8e5a075942f4d2ee8ca1d9ebe3005e&authtype=sso&custid=ns315887.